CARDIO DIAGNOSTICS HOLDINGS INC (CDIO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.86+1.64%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CDIO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Total Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 0.6 | 0.6 | 0.0 | 0.1 | 0.0 | 0.0 | — |
| Operating Income | (6.5) | (6.5) | (8.4) | (7.2) | (4.5) | (0.6) | — |
| Earnings from Continuing Operations | |||||||
| Interest Expense | 0.0 | 0.0 | 0.0 | 6.7 | — | — | — |
| EBT, Incl. Unusual Items | (6.5) | (6.5) | (8.4) | (8.4) | (4.7) | (0.6) | — |
| Income Tax Expense | — | — | — | — | 0.0 | 0.0 | — |
| Net Income | |||||||
| Net Income | (6.5) | (6.5) | (8.4) | (8.4) | (4.7) | (0.6) | — |
| Per Share | |||||||
| Basic EPS | (2.19) | (3.71) | (0.31) | (0.66) | (1.51) | (0.53) | — |
| Diluted EPS | (2.19) | (3.71) | (0.31) | (0.66) | (1.51) | (0.53) | — |
| Revenue per Share | 0.00 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 3.0 | 1.8 | 26.9 | 12.7 | 3.1 | 1.2 | — |
| Diluted Weighted Avg Shares | 3.0 | 1.8 | 26.9 | 12.7 | 3.1 | 1.2 | — |
| Supplemental | |||||||
| EBITDA | — | (6.4) | (8.3) | (7.2) | (4.5) | (0.6) | — |
| EBIT | (6.5) | (6.5) | (8.4) | (7.2) | (4.5) | (0.6) | — |
| Effective Tax Rate | — | — | — | — | 0.0% | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.